Cargando…
Low-dose interleukin-2 therapy in systemic lupus erythematosus
In systemic lupus erythematosus (SLE), T regulatory cells (T(regs)) contribute to the inhibition of autoimmune responses by suppressing self-reactive immune cells. Interleukin (IL)-2 plays an essential role in the generation, function and homeostasis of the T(regs) and is reduced in SLE. Several cli...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
De Gruyter
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538619/ https://www.ncbi.nlm.nih.gov/pubmed/37781677 http://dx.doi.org/10.2478/rir-2023-0021 |